1992年8月至10月，研究人员在南加州大都会水区（MWDSC）5.5-mgd示范工厂进行了初步强化混凝试验。对加利福尼亚州项目用水和科罗拉多河水进行了测试。第一个目标是确定这种操作模式是否是控制MWDSC设施消毒副产物（DBP）和DBP前体的有效策略。如果这一策略被证明是成功的，第二个目标是估计遵守拟议的消毒剂/DBP规则的额外运营成本，并确定将这些成本降至最低的凝血条件。虽然结果表明，强化混凝可以满足该规则所考虑的标准，但这一过程将增加MWDSC的处理成本。 包括19个参考文献、表格和图表。

Researchers conducted prelimary enchanced coagulation tests at the Metropolitan Water Distict of Southern California's (MWDSC's) 5.5-mgd demonstration plant from August to October 1992. California State project water and Colorado River water were tested. The first goal was to determine whether this mode of operation is an effective strategy for controlling disinfection byproducts (DBPs) and DBP precursors at MWDSC facilities. If this strategy proved to be successful, the second objective was to estimate the additional operational costs of complying with the proposed Disinfectants/DBP Rule and to identify the coagulation conditions that minimize these costs. Although the results show that enhanced coagulation can meet the criteria being considered for the rule, this process will increase MWDSC's cost of treatment. Includes 19 references, tables, figures.